PATENT CLAIM ANALYSIS

Application Number: 16204364
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["546", "273400"]

Abstract:
Piperidine compounds and pharmaceutically useful salts thereof, a pharmaceutical composition including an effective amount of the racemic or enantiomerically enriched piperidine compounds to treat gastrointestinal diseases, and a method of treating gastrointestinal diseases in a mammal are provided.

Claim (Index 24):
The method of  claim 23 , wherein the reaction is performed at the amount of 0.005 to 0.1 moles of the compound represented by the structural formula (XI), with 1.1 to 3.0 equivalents of an epoxide represented by the structural formula (XIII).

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 1.24242
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15618252', '12576494', '14158517', '15248872', '13641867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7881940306543841
- 35 USC 102 Novelty (BERT): 0.5432637169322083
- Combined Prediction Score: 0.7637009992821665
- Mean Citation Score: 351.451378
- Max Citation Score: 385.73358
- Similarity Product: 288.5052764290595

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test